Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw™
  • Log in to access your subscriptions

MenuIn depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
  • In depth. On point.
Securities Regulation Daily Wrap Up
    • WHISTLEBLOWER NEWS—2d. Cir.: SOX whistleblower must prove retaliatory intent
    • ISSUER REGISTRATION—Seasoned issuer to SEC: 'please amend Reg. A to allow ‘shelf’ offerings'
    • ENFORCEMENT—4TH Cir.: Disgorgement order for control person upheld on appeal
    • FRAUD AND MANIPULATION—D.N.J.: No misleading statements about teplizumab drug studies and trials
    • WORTH NOTING—Other litigation, regulatory activity and industry news
  • ShareLinkedIn

    © 2022 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Privacy & Cookies